Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine
about
Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skinRegulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120.HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesDose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaquesPotential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensInduction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination
P2860
Q31148797-528270F2-EFF8-4F20-A5A2-825969EC4640Q33613835-FCFC3EC9-2387-49FD-947D-198F6E355FD5Q33723334-2D4842BE-2FC4-437F-A9FF-87EF89E811FFQ33763297-E042BED6-A75A-424F-B452-CE7CE150D0E4Q34369139-EF378C6D-A852-4CEC-B687-2614E0893581Q34487151-5236D05F-0802-48FC-B994-48D5157DAC28Q34653619-8DBB185F-337A-4E8C-8C27-45231AC38476Q34991112-1A0FD2C9-E21C-4E25-A08B-04C5A87E9B2FQ35826742-E7EADA22-F0EC-4814-BAE5-88D8398E1A0FQ35883750-C76AD284-B4F7-409F-A455-C8304B7ABF24Q35886963-36F82479-3F63-419F-BFB1-DB979A5EB2D4Q35914311-5653ED18-0FB8-4438-87A6-6536058D0C0AQ36256319-53554C04-BF2B-470F-BBC4-E759ADB200A3Q36736400-DAAF74AB-D30C-4E1D-977E-74266DE41365Q37628079-DF6EA721-EB25-40A6-81D1-1C67E4F25926Q45873868-0CDD9BA1-91BE-4DDC-9A77-AA42227EDE60Q53272516-8EFC6E7E-73CC-4DEF-A10B-A74E05EE021DQ58711069-EF3BE48B-E798-4A40-87FD-6D51BF18030E
P2860
Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@ast
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@en
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@nl
type
label
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@ast
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@en
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@nl
prefLabel
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@ast
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@en
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@nl
P2093
P2860
P1433
P1476
Altering an artificial Gagpoln ...... y of a clade C HIV DNA vaccine
@en
P2093
Josef Köstler
Katharina Böckl
Kathrin Kindsmüller
Ralf Wagner
Simon Bredl
P2860
P304
P356
10.1371/JOURNAL.PONE.0034723
P407
P577
2012-01-01T00:00:00Z